compare glp-1 for weight loss Bariatric Surgery Outperforms GLP-1s in Comparative efficacy and safety of

With consumer and prescriber interest in GLP-1 receptor agonist drugs soaring, health plan managers have a new source of financial stress and clinical questions on their to-do list

The study was done from May 2009 to December 2011

transient headache, nausea, fatigue

Reliance Foundation Hospital, Mumbai, explains the euphoria: Newer agents in this family, and dual incretin drugs such as tirzepatide, have changed the conversation because, for the first time, we have medicines that can produce meaningful and, sometimes, dramatic weight reduction

doi: 10.1107/s090744490001458x 137 MorozOVDodsonGGWilsonKSLukanidinEBronsteinIB